Metraipolis › archive › dc_2f2b1679ca90

PHD Inhibitor Vadadustat: The First Drug Therapy for Triosephosphate Isomerase Deficiency — Europe PMC PMID:42938308

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42938308
DOI
10.3390/genes17101192
License (as archived)
solo-consultazione
Archived
2026-11-01T03:13:47.367Z
SHA-256 of the archived text
4c6a466ed7b5a00d950e696b3c33955e2335a1aa42f4badaa2f40163e41aa2d9
Stable URL of this page
https://metraipolis.com/documento/dc_2f2b1679ca90

How to cite

PHD Inhibitor Vadadustat: The First Drug Therapy for Triosephosphate Isomerase Deficiency — Europe PMC PMID:42938308 — Europe PMC (en), https://europepmc.org/article/MED/42938308 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f2b1679ca90 (Metraipolis archive dc_2f2b1679ca90, sha256 4c6a466ed7b5a00d950e696b3c33955e2335a1aa42f4badaa2f40163e41aa2d9)
BibTeX
@misc{dc2f2b1679ca90,
  title = {PHD Inhibitor Vadadustat: The First Drug Therapy for Triosephosphate Isomerase Deficiency — Europe PMC PMID:42938308},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42938308},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f2b1679ca90; sha256 4c6a466ed7b5a00d950e696b3c33955e2335a1aa42f4badaa2f40163e41aa2d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42938308. Agents can read the archived copy with the MCP tool read_document.